Respiratory Disease Testing Market Size, Share, Growth Report 2032

Respiratory Disease Testing Market

Respiratory Disease Testing Market by Product (Lung Volume, Imaging, Spirometry, Peak Flow, Blood Gas, and Other Tests), By End-user (Hospitals, Physician Offices, and Clinical Laboratories): Global Industry Perspective, Comprehensive Analysis and Forecast, 2024 - 2032

Category: Medical Device Report Format : PDF Pages: 140 Report Code: ZMR-114 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 7.77 Billion USD 15.99 Billion 8.35% 2023

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Product
        • 2.1.1.2. Market Attractiveness Analysis, By End-user
        • 2.1.1.3. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Respiratory Disease Testing Market, 2016 – 2028 (USD Billion)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Respiratory Disease Testing Market – Product Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Product, 2020 & 2028
    • 4.2. Lung Vulume
      • 4.2.1. Market Size and Forecast, By Region (USD Billion)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Imaging
      • 4.3.1. Market Size and Forecast, By Region (USD Billion)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Spirometry
      • 4.4.1. Market Size and Forecast, By Region (USD Billion)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.5. Peak Flow
      • 4.5.1. Market Size and Forecast, By Region (USD Billion)
      • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.6. Blood Gas
      • 4.6.1. Market Size and Forecast, By Region (USD Billion)
      • 4.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.7. Other Tests
      • 4.7.1. Market Size and Forecast, By Region (USD Billion)
      • 4.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.7.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Respiratory Disease Testing Market – End-user Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By End-user, 2020 & 2028
    • 5.2. Hospitals
      • 5.2.1. Market Size and Forecast, By Region (USD Billion)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Physician Offices
      • 5.3.1. Market Size and Forecast, By Region (USD Billion)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Clinical Laboratories
      • 5.4.1. Market Size and Forecast, By Region (USD Billion)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6 Respiratory Disease Testing Market – Regional Analysis
    • 6.1. Overview
      • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 6.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
    • 6.2. North America
      • 6.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.2.2. North America Market Revenue, By Product, 2016 – 2028
      • 6.2.3. North America Market Revenue, By End-user, 2016 – 2028
      • 6.2.5. U.S.
        • 6.2.5.1. U.S. Market Revenue, By Product, 2016 – 2028
        • 6.2.5.2. U.S. Market Revenue, By End-user, 2016 – 2028
      • 6.2.6. Canada
        • 6.2.6.1. Canada Market Revenue, By Product, 2016 – 2028
        • 6.2.6.2. Canada Market Revenue, By End-user, 2016 – 2028
      • 6.2.7. Mexico
        • 6.2.7.1. Mexico Market Revenue, By Product, 2016 – 2028
        • 6.2.7.2. Mexico Market Revenue, By End-user, 2016 – 2028
    • 6.3. Europe
      • 6.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.3.2. Europe Market Revenue, By Product, 2016 – 2028
      • 6.3.3. Europe Market Revenue, By End-user, 2016 – 2028
      • 6.3.5. Germany
        • 6.3.5.1. Germany Market Revenue, By Product, 2016 – 2028
        • 6.3.5.2. Germany Market Revenue, By End-user, 2016 – 2028
      • 6.3.6. France
        • 6.3.6.1. France Market Revenue, By Product, 2016 – 2028
        • 6.3.6.2. France Market Revenue, By End-user, 2016 – 2028
      • 6.3.7. U.K.
        • 6.3.7.1. U.K. Market Revenue, By Product, 2016 – 2028
        • 6.3.7.2. U.K. Market Revenue, By End-user, 2016 – 2028
      • 6.3.8. Italy
        • 6.3.8.1. Italy Market Revenue, By Product, 2016 – 2028
        • 6.3.8.2. Italy Market Revenue, By End-user, 2016 – 2028
      • 6.3.9. Spain
        • 6.3.9.1. Spain Market Revenue, By Product, 2016 – 2028
        • 6.3.9.2. Spain Market Revenue, By End-user, 2016 – 2028
      • 6.3.10. Rest of Europe
        • 6.3.10.1. Rest of Europe Market Revenue, By Product, 2016 – 2028
        • 6.3.10.2. Rest of Europe Market Revenue, By End-user, 2016 – 2028
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.4.2. Asia Pacific Market Revenue, By Product, 2016 – 2028
      • 6.4.3. Asia Pacific Market Revenue, By End-user, 2016 – 2028
      • 6.4.5. China
        • 6.4.5.1. China Market Revenue, By Product, 2016 – 2028
        • 6.4.5.2. China Market Revenue, By End-user, 2016 – 2028
      • 6.4.6. Japan
        • 6.4.6.1. Japan Market Revenue, By Product, 2016 – 2028
        • 6.4.6.2. Japan Market Revenue, By End-user, 2016 – 2028
      • 6.4.7. India
        • 6.4.7.1. India Market Revenue, By Product, 2016 – 2028
        • 6.4.7.2. India Market Revenue, By End-user, 2016 – 2028
      • 6.4.8. South Korea
        • 6.4.8.1. South Korea Market Revenue, By Product, 2016 – 2028
        • 6.4.8.2. South Korea Market Revenue, By End-user, 2016 – 2028
      • 6.4.9. South-East Asia
        • 6.4.9.1. South-East Asia Market Revenue, By Product, 2016 – 2028
        • 6.4.9.2. South-East Asia Market Revenue, By End-user, 2016 – 2028
      • 6.4.10. Rest of Asia Pacific
        • 6.4.10.1. Rest of Asia Pacific Market Revenue, By Product, 2016 – 2028
        • 6.4.10.2. Rest of Asia Pacific Market Revenue, By End-user, 2016 – 2028
    • 6.5. Latin America
      • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.5.2. Latin America Market Revenue, By Product, 2016 – 2028
      • 6.5.3. Latin America Market Revenue, By End-user, 2016 – 2028
      • 6.5.5. Brazil
        • 6.5.5.1. Brazil Market Revenue, By Product, 2016 – 2028
        • 6.5.5.2. Brazil Market Revenue, By End-user, 2016 – 2028
      • 6.5.6. Argentina
        • 6.5.6.1. Argentina Market Revenue, By Product, 2016 – 2028
        • 6.5.6.2. Argentina Market Revenue, By End-user, 2016 – 2028
      • 6.5.7. Rest of Latin America
        • 6.5.7.1. Rest of Latin America Market Revenue, By Product, 2016 – 2028
        • 6.5.7.2. Rest of Latin America Market Revenue, By End-user, 2016 – 2028
    • 6.6. The Middle-East and Africa
      • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 6.6.2. The Middle-East and Africa Market Revenue, By Product, 2016 – 2028
      • 6.6.3. The Middle-East and Africa Market Revenue, By End-user, 2016 – 2028
      • 6.6.5. GCC Countries
        • 6.6.5.1. GCC Countries Market Revenue, By Product, 2016 – 2028
        • 6.6.5.2. GCC Countries Market Revenue, By End-user, 2016 – 2028
      • 6.6.6. South Africa
        • 6.6.6.1. South Africa Market Revenue, By Product, 2016 – 2028
        • 6.6.6.2. South Africa Market Revenue, By End-user, 2016 – 2028
      • 6.6.7. Rest of Middle-East Africa
        • 6.6.7.1. Rest of Middle-East Africa Market Revenue, By Product, 2016 – 2028
        • 6.6.7.2. Rest of Middle-East Africa Market Revenue, By End-user, 2016 – 2028
  • Chapter No. 7: Respiratory Disease Testing Market – Industry Analysis
    • 7.1. Introduction
    • 7.2. Market Drivers
      • 7.2.1. Driving Factor 1 Analysis
      • 7.2.2. Driving Factor 2 Analysis
    • 7.3. Market Restraints
      • 7.3.1. Restraining Factor Analysis
    • 7.4. Market Opportunities
      • 7.4.1. Market Opportunity Analysis
    • 7.5. Porter’s Five Forces Analysis
    • 7.6. PEST Analysis
    • 7.7. Regulatory Landscape
    • 7.8. Technology Landscape
    • 7.9. Regional Market Trends
      • 7.9.1. North America
      • 7.9.2. Europe
      • 7.9.3. Asia Pacific
      • 7.9.4. Latin America
      • 7.9.5. The Middle-East and Africa
    • 7.10. Pricing Analysis
    • 7.11. Value Chain Analysis
    • 7.12. Downstream Buyers
    • 7.13. Distributors/Traders List
  • Chapter No. 8: Competitive Landscape
    • 8.1. Company Market Share Analysis – 2019
      • 8.1.1. Global Respiratory Disease Testing Market: Company Market Share, 2019
      • 8.1.2. Global Respiratory Disease Testing Market, Company Market Revenue, 2016 – 2019 (USD Billion)
      • 8.1.3. Global Respiratory Disease Testing Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 8.1.4. Global Respiratory Disease Testing Market: Radar Determinant Chart, 2019
    • 8.2. Strategic Developments
      • 8.2.1. Acquisitions & Mergers
      • 8.2.2. New Product Launch
      • 8.2.3. Regional Expansion
    • 8.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 9: Company Profiles
    • 9.1. Medical Technulogies, Inc.
      • 9.1.1. Company Overview
      • 9.1.2. Key Executives
      • 9.1.3. Product Portfolio
      • 9.1.4. Financial Overview
      • 9.1.5. Operating Business Segments
      • 9.1.6. Business Performance
      • 9.1.7. Recent Developments
    • 9.2. Carestream Health, Inc.
    • 9.3. SDI Diagnostics
    • 9.4. Nihon Kohden Corporation
    • 9.5. CareFusion Corporation
    • 9.6. Smiths Medical
    • 9.7. COSMED
    • 9.8. Perkin Elmer, Inc.
    • 9.9. Philips Healthcare
    • 9.10. MGC Diagnostic Corporation
    • 9.11 Futuremed America, Inc.
  • Chapter No. 10: Marketing Strategy Analysis
    • 10.1. Marketing Channel
    • 10.2. Direct Marketing
    • 10.3. Indirect Marketing
    • 10.4. Marketing Channel Development Trends
    • 10.5. Economic/Pulitical Environmental Change
  • Chapter No. 11: Research Methodology
    • 11.1. Research Methodology
    • 11.2. Phase I - Secondary Research
    • 11.3. Phase II - Data Modeling
      • 11.3.1. Company Share Analysis Model
      • 11.3.2. Revenue Based Modeling
    • 11.4. Phase III - Primary Research
    • 11.5. Research Limitations
      • 11.5.1. Assumptions

Table Of Figures

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Product
FIG NO. 2. Market Attractiveness Analysis, By End-user
FIG NO. 3. Market Attractiveness Analysis, By Region
FIG NO. 4. Global Respiratory Disease Testing Market Revenue, 2016 – 2028 (USD Billion)
FIG NO. 5. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 6. Market Revenue Share, By Product, 2020 & 2028 
FIG NO. 7. Global Respiratory Disease Testing Market for Lung Volume, Revenue (USD Billion) 2016 – 2028
FIG NO. 8. Comparative Revenue Analysis of Respiratory Disease Testing Market for Lung Volume, By Country, 2020 & 2028
FIG NO. 9. Global Respiratory Disease Testing Market for Imaging, Revenue (USD Billion) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Respiratory Disease Testing Market for Imaging, By Country, 2020 & 2028
FIG NO. 11. Global Respiratory Disease Testing Market for Spirometry, Revenue (USD Billion) 2016 – 2028
FIG NO. 12. Comparative Revenue Analysis of Respiratory Disease Testing Market for Spirometry, By Country, 2020 & 2028
FIG NO. 13. Global Respiratory Disease Testing Market for Peak Flow, Revenue (USD Billion) 2016 – 2028
FIG NO. 14. Comparative Revenue Analysis of Respiratory Disease Testing Market for Peak Flow, By Country, 2020 & 2028
FIG NO. 15. Global Respiratory Disease Testing Market for Blood Gas, Revenue (USD Billion) 2016 – 2028
FIG NO. 16. Comparative Revenue Analysis of Respiratory Disease Testing Market for Blood Gas, By Country, 2020 & 2028
FIG NO. 17. Global Respiratory Disease Testing Market for Other Tests, Revenue (USD Billion) 2016 – 2028
FIG NO. 18. Comparative Revenue Analysis of Respiratory Disease Testing Market for Other Tests, By Country, 2020 & 2028
FIG NO. 19. Market Revenue Share, By End-user, 2020 & 2028
FIG NO. 20. Global Respiratory Disease Testing Market for Hospitals, Revenue (USD Billion) 2016 – 2028
FIG NO. 21. Comparative Revenue Analysis of Respiratory Disease Testing Market for Hospitals, By Country, 2020 & 2028 
FIG NO. 22. Global Respiratory Disease Testing Market for Physician Offices, Revenue (USD Billion) 2016 – 2028
FIG NO. 23. Comparative Revenue Analysis of Respiratory Disease Testing Market for Physician Offices, By Country, 2020 & 2028
FIG NO. 24. Global Respiratory Disease Testing Market for Clinical Laboratories, Revenue (USD Billion) 2016 – 2028 
FIG NO. 25. Comparative Revenue Analysis of Respiratory Disease Testing Market for Clinical Laboratories, By Country, 2020 & 2028
FIG NO. 26. Global Respiratory Disease Testing Market Revenue Share, By Region, 2020 & 2028
FIG NO. 27. North America Respiratory Disease Testing Market Revenue, 2016 - 2028 (USD Billion)
FIG NO. 28. Porter’s Five Forces Analysis for Global Respiratory Disease Testing Market
FIG NO. 29. PEST Analysis for Global Respiratory Disease Testing Market
FIG NO. 30. Pricing Analysis for Global Respiratory Disease Testing Market
FIG NO. 31. Value Chain Analysis for Global Respiratory Disease Testing Market
FIG NO. 32. Company Share Analysis, 2019
FIG NO. 33. Radar Determinant Chart, 2019
FIG NO. 34. Company Strategic Developments – Heat Map Analysis
FIG NO. 35. Medical Technologies, Inc. Business Segment Revenue Share, 2020 (%)
FIG NO. 36. Medical Technologies, Inc. Geographical Segment Revenue Share, 2020 (%)
FIG NO. 37. Market Channels
FIG NO. 38. Marketing Channel Development Trend
FIG NO. 39. Growth in World Gross Product, 2008-2018
FIG NO. 40. Research Methodology – Detailed View
FIG NO. 41. Research Methodology
 


Table Of Tables

List of Tables 

TABLE NO. 1. Global Respiratory Disease Testing Market: Snapshot
TABLE NO. 2. Quarterly Respiratory Disease Testing Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Respiratory Disease Testing Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion) 
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion) 
TABLE NO. 6. Global Respiratory Disease Testing Market for Lung Volume, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 7. Global Respiratory Disease Testing Market for Imaging, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 8. Global Respiratory Disease Testing Market for Spirometry, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 9. Global Respiratory Disease Testing Market for Peak Flow, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 10. Global Respiratory Disease Testing Market for Blood Gas, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 11. Global Respiratory Disease Testing Market for Other Tests, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 12. Global Respiratory Disease Testing Market for Hospitals, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 13 Global Respiratory Disease Testing Market for Physician Offices, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 14. Global Respiratory Disease Testing Market for Clinical Laboratories, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 15. Global Respiratory Disease Testing Market Revenue, By Region, 2016 – 2028 (USD Billion)
TABLE NO. 16. North America Respiratory Disease Testing Market Revenue, By Country, 2016 – 2028 (USD Billion)
TABLE NO. 17. North America Respiratory Disease Testing Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 18. North America Respiratory Disease Testing Market Revenue, By End-user, 2016 – 2028 (USD Billion)
TABLE NO. 19. U.S. Respiratory Disease Testing Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 20. U.S. Respiratory Disease Testing Market Revenue, By End-user, 2016 – 2028 (USD Billion)
TABLE NO. 21. Canada Respiratory Disease Testing Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 22. Canada Respiratory Disease Testing Market Revenue, By End-user, 2016 – 2028 (USD Billion)
TABLE NO. 23. Mexico Respiratory Disease Testing Market Revenue, By Product, 2016 – 2028 (USD Billion)
TABLE NO. 24. Mexico Respiratory Disease Testing Market Revenue, By End-user, 2016 – 2028 (USD Billion)
TABLE NO. 25. Drivers for the Respiratory Disease Testing Market: Impact Analysis
TABLE NO. 26. Restraints for the Respiratory Disease Testing Market: Impact Analysis
TABLE NO. 27. Major Buyers of Respiratory Disease Testing  
TABLE NO. 28. Distributors/Traders List of Respiratory Disease Testing
TABLE NO. 29. Global Respiratory Disease Testing Market, Company Market Revenue, 2016 – 2019 (USD Billion) 
TABLE NO. 30: Global Respiratory Disease Testing Market, Company Y-o-Y Growth, 2017 – 2019 (USD Billion)   


 

Methodology

FrequentlyAsked Questions

The global Respiratory Disease Testing Market was valued at USD 7.77 Billion in 2023.

The global Respiratory Disease Testing Market is expected to reach USD 15.99 Billion by 2032, with a CAGR of around 8.35% between 2024-2032.

Some of the key factors driving the global Respiratory Disease Testing Market growth are increasing prevalence of various respiratory diseases and growing aged population.

North America is expected to remain the dominant region over the forecast period. North America followed by Asia-Pacific and Europe in terms of demand for Respiratory Disease Testing.

Some of the major players of global Respiratory Disease Testing market Medical Technologies, Inc., Carestream Health, Inc., SDI Diagnostics, Nihon Kohden Corporation, CareFusion Corporation, Smiths Medical, COSMED, Perkin Elmer, Inc., Philips Healthcare, MGC Diagnostic Corporation, Futuremed America, Inc. and GE Healthcare among others.

  • zion payment modes

List of Contents

Market InsightsOverview Growth FactorsReport ScopeSegment Analysis Preview Regional Analysis Preview Key Players Competitive LandscapeThe global Market is segmented as follows:

HappyClients